Published in Clin Lung Cancer on January 01, 2005
Reversal by RARα agonist Am580 of c-Myc-induced imbalance in RARα/RARγ expression during MMTV-Myc tumorigenesis. Breast Cancer Res (2012) 0.91
Retinoids and rexinoids in cancer prevention: from laboratory to clinic. Semin Oncol (2015) 0.81
Cancer-preventive rexinoid modulates neutral lipid contents of mammary epithelial cells through a peroxisome proliferator-activated receptor γ-dependent mechanism. Mol Pharmacol (2011) 0.79
Pharmacological Modulation of Lung Carcinogenesis in Smokers: Preclinical and Clinical Evidence. Trends Pharmacol Sci (2015) 0.77
Expression profiling of mammalian microRNAs uncovers a subset of brain-expressed microRNAs with possible roles in murine and human neuronal differentiation. Genome Biol (2004) 15.15
RAS mutations in cutaneous squamous-cell carcinomas in patients treated with BRAF inhibitors. N Engl J Med (2012) 6.93
Adductor canal block versus femoral nerve block for total knee arthroplasty: a prospective, randomized, controlled trial. Anesthesiology (2014) 3.80
Perioperative outcomes after unilateral and bilateral total knee arthroplasty. Anesthesiology (2009) 3.66
MicroRNA-31 functions as an oncogenic microRNA in mouse and human lung cancer cells by repressing specific tumor suppressors. J Clin Invest (2010) 2.87
Structural basis for assembly and function of a heterodimeric plant immune receptor. Science (2014) 2.34
Uncovering growth-suppressive MicroRNAs in lung cancer. Clin Cancer Res (2009) 2.19
Urinary brain-derived neurotrophic factor: a potential biomarker for objective diagnosis of overactive bladder. Int Urol Nephrol (2013) 2.07
Retinoids in cancer therapy and chemoprevention: promise meets resistance. Oncogene (2003) 2.02
A cross-sectional survey on prevalence and risk factors for persistent postsurgical pain 1 year after total hip and knee replacement. Reg Anesth Pain Med (2012) 1.86
Incorporating bevacizumab and erlotinib in the combined-modality treatment of stage III non-small-cell lung cancer: results of a phase I/II trial. J Clin Oncol (2012) 1.84
The synthetic triterpenoids CDDO-methyl ester and CDDO-ethyl amide prevent lung cancer induced by vinyl carbamate in A/J mice. Cancer Res (2007) 1.81
Perioperative pulmonary outcomes in patients with sleep apnea after noncardiac surgery. Anesth Analg (2010) 1.80
Lung cancer in a U.S. population with low to moderate arsenic exposure. Environ Health Perspect (2009) 1.77
Specific chemopreventive agents trigger proteasomal degradation of G1 cyclins: implications for combination therapy. Clin Cancer Res (2004) 1.68
A novel retinoic acid receptor beta isoform and retinoid resistance in lung carcinogenesis. J Natl Cancer Inst (2005) 1.67
The metabolic syndrome in patients undergoing knee and hip arthroplasty: trends and in-hospital outcomes in the United States. J Arthroplasty (2012) 1.65
Discrimination of intact mycobacteria at the strain level: a combined MALDI-TOF MS and biostatistical analysis. Proteomics (2006) 1.62
Transgenic cyclin E triggers dysplasia and multiple pulmonary adenocarcinomas. Proc Natl Acad Sci U S A (2007) 1.61
Bexarotene plus erlotinib suppress lung carcinogenesis independent of KRAS mutations in two clinical trials and transgenic models. Cancer Prev Res (Phila) (2011) 1.61
Evidence for the epidermal growth factor receptor as a target for lung cancer prevention. Clin Cancer Res (2002) 1.61
Cartilage injury after acute, isolated anterior cruciate ligament tear: immediate and longitudinal effect with clinical/MRI follow-up. Am J Sports Med (2011) 1.58
Adjuvant vinorelbine and cisplatin in elderly patients: National Cancer Institute of Canada and Intergroup Study JBR.10. J Clin Oncol (2007) 1.57
Constructing molecular classifiers for the accurate prognosis of lung adenocarcinoma. Clin Cancer Res (2006) 1.55
Factors influencing unexpected disposition after orthopedic ambulatory surgery. J Clin Anesth (2012) 1.51
Trends in in-hospital major morbidity and mortality after total joint arthroplasty: United States 1998-2008. Anesth Analg (2012) 1.45
Pathological neovascularization is reduced by inactivation of ADAM17 in endothelial cells but not in pericytes. Circ Res (2010) 1.42
A retinoic acid-dependent checkpoint in the development of CD4+ T cell-mediated immunity. J Exp Med (2011) 1.41
Multilayered epithelium in a rat model and human Barrett's esophagus: similar expression patterns of transcription factors and differentiation markers. BMC Gastroenterol (2008) 1.38
Secondary prevention of venous thromboembolic events in patients with active cancer: enoxaparin alone versus initial enoxaparin followed by warfarin for a 180-day period. Clin Appl Thromb Hemost (2006) 1.35
The gene expression signature of genomic instability in breast cancer is an independent predictor of clinical outcome. Int J Cancer (2009) 1.34
Apple allergy across Europe: how allergen sensitization profiles determine the clinical expression of allergies to plant foods. J Allergy Clin Immunol (2006) 1.30
Bexarotene and erlotinib for aerodigestive tract cancer. J Clin Oncol (2005) 1.30
The dynamic face of HIV-1 subtypes among men who have sex with men in Beijing, China. Curr HIV Res (2011) 1.26
A humanized anti-IL-6 antibody (ALD518) in non-small cell lung cancer. Expert Opin Biol Ther (2011) 1.26
Overcoming CYP1A1/1A2 mediated induction of metabolism by escalating erlotinib dose in current smokers. J Clin Oncol (2009) 1.26
Functional role of vanilloid transient receptor potential 4-canonical transient receptor potential 1 complex in flow-induced Ca2+ influx. Arterioscler Thromb Vasc Biol (2010) 1.25
Distinct and overlapping sarcoma subtypes initiated from muscle stem and progenitor cells. Cell Rep (2013) 1.24
National trends in anterior cervical fusion procedures. Spine (Phila Pa 1976) (2010) 1.24
G0S2 is an all-trans-retinoic acid target gene. Int J Oncol (2008) 1.23
Epidermal growth factor receptor tyrosine kinase inhibitors as initial therapy for non-small cell lung cancer: focus on epidermal growth factor receptor mutation testing and mutation-positive patients. Cancer Treat Rev (2013) 1.23
Molecular epidemiology of measles viruses in China, 1995-2003. Virol J (2007) 1.20
Alpha-1-acid glycoprotein as an independent predictor for treatment effects and a prognostic factor of survival in patients with non-small cell lung cancer treated with docetaxel. Clin Cancer Res (2003) 1.18
Epidermal growth factor receptor tyrosine kinase inhibition represses cyclin D1 in aerodigestive tract cancers. Clin Cancer Res (2004) 1.16
UBE1L is a retinoid target that triggers PML/RARalpha degradation and apoptosis in acute promyelocytic leukemia. Proc Natl Acad Sci U S A (2002) 1.16
Involvement of UBE1L in ISG15 conjugation during retinoid-induced differentiation of acute promyelocytic leukemia. J Biol Chem (2004) 1.14
In-hospital surgical site infections after primary hip and knee arthroplasty--incidence and risk factors. J Arthroplasty (2012) 1.13
Oncogene-dependent control of miRNA biogenesis and metastatic progression in a model of undifferentiated pleomorphic sarcoma. J Pathol (2012) 1.12
Mortality of patients with respiratory insufficiency and adult respiratory distress syndrome after surgery: the obesity paradox. J Intensive Care Med (2011) 1.12
Predictors for moderate to severe acute postoperative pain after total hip and knee replacement. Int Orthop (2012) 1.11
Perioperative mortality in patients with pulmonary hypertension undergoing major joint replacement. Anesth Analg (2010) 1.10
Targeting the cyclin E-Cdk-2 complex represses lung cancer growth by triggering anaphase catastrophe. Clin Cancer Res (2009) 1.10
Dual-energy micro-computed tomography imaging of radiation-induced vascular changes in primary mouse sarcomas. Int J Radiat Oncol Biol Phys (2012) 1.10
A retinoic acid--rich tumor microenvironment provides clonal survival cues for tumor-specific CD8(+) T cells. Cancer Res (2012) 1.09
UBE1L causes lung cancer growth suppression by targeting cyclin D1. Mol Cancer Ther (2008) 1.09
MicroRNA-182 drives metastasis of primary sarcomas by targeting multiple genes. J Clin Invest (2014) 1.09
Perioperative pulmonary circulatory changes during bilateral total hip arthroplasty under regional anesthesia. Reg Anesth Pain Med (2010) 1.08
Fingerprint quality control of Tianjihuang by high-performance liquid chromatography-photodiode array detection. J Chromatogr A (2005) 1.07
Cyclin degradation for cancer therapy and chemoprevention. J Cell Biochem (2007) 1.07
Perioperative morbidity and mortality after anterior, posterior, and anterior/posterior spine fusion surgery. Spine (Phila Pa 1976) (2011) 1.07
The utility of serum hepcidin as a biomarker for late-onset neonatal sepsis. J Pediatr (2012) 1.06
Reliability and validity of the PHQ-9 for screening late-life depression in Chinese primary care. Int J Geriatr Psychiatry (2010) 1.05
Maternal obesity markedly increases placental fatty acid transporter expression and fetal blood triglycerides at midgestation in the ewe. Am J Physiol Regul Integr Comp Physiol (2010) 1.05
Hedgehog-producing cancer cells respond to and require autocrine Hedgehog activity. Cancer Res (2011) 1.05
Dynamic contact mechanics of radial tears of the lateral meniscus: implications for treatment. Arthroscopy (2011) 1.05
Bilateral total knee arthroplasty: risk factors for major morbidity and mortality. Anesth Analg (2011) 1.04
A proof-of-principle clinical trial of bexarotene in patients with non-small cell lung cancer. Clin Cancer Res (2007) 1.04
Microarray analysis uncovers retinoid targets in human bronchial epithelial cells. Oncogene (2003) 1.04
Differential gene expression in normal esophagus and Barrett's esophagus. J Gastroenterol (2009) 1.03
The interaction between OsMADS57 and OsTB1 modulates rice tillering via DWARF14. Nat Commun (2013) 1.03
Correction for chromosome-17 is critical for the determination of true Her-2/neu gene amplification status in breast cancer. Mol Cancer Ther (2006) 1.03
Randomized phase II multicenter trial of two schedules of lapatinib as first- or second-line monotherapy in patients with advanced or metastatic non-small cell lung cancer. Clin Cancer Res (2010) 1.03
Functional studies on the IBD susceptibility gene IL23R implicate reduced receptor function in the protective genetic variant R381Q. PLoS One (2011) 1.03
Subsartorial adductor canal vs femoral nerve block for analgesia after total knee replacement. Int Orthop (2014) 1.02
Stage-stratified analysis of prognostic significance of tumor size in patients with gastric cancer. PLoS One (2013) 1.01
Epidemiology and risk factors for perioperative mortality after total hip and knee arthroplasty. J Orthop Res (2012) 1.01
Stabilized liposomal nanohybrid cerasomes for drug delivery applications. Chem Commun (Camb) (2010) 1.01
Increased in-hospital complications after primary posterior versus primary anterior cervical fusion. Clin Orthop Relat Res (2011) 1.01
A rapid LC/MS/MS quantitation assay for naringin and its two metabolites in rats plasma. J Pharm Biomed Anal (2006) 1.01
Prevalence of overweight and obesity in adolescents with severe mental illness: a cross-sectional chart review. J Clin Psychiatry (2010) 1.00
High DNA methyltransferase 3B expression mediates 5-aza-deoxycytidine hypersensitivity in testicular germ cell tumors. Cancer Res (2009) 0.99
Cyclin E transgenic mice: discovery tools for lung cancer biology, therapy, and prevention. Cancer Prev Res (Phila) (2010) 0.99
The rexinoid LG100268 and the synthetic triterpenoid CDDO-methyl amide are more potent than erlotinib for prevention of mouse lung carcinogenesis. Mol Cancer Ther (2008) 0.98
p53 functions in endothelial cells to prevent radiation-induced myocardial injury in mice. Sci Signal (2012) 0.98
Disulfide bond bridge insertion turns hydrophobic anticancer prodrugs into self-assembled nanomedicines. Nano Lett (2014) 0.98
Atm deletion with dual recombinase technology preferentially radiosensitizes tumor endothelium. J Clin Invest (2014) 0.98